SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CALO', Girolamo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.111
AS - Asia 11.868
EU - Europa 7.555
SA - Sud America 1.913
AF - Africa 195
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 50.676
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.647
SG - Singapore 4.898
CN - Cina 3.412
DE - Germania 1.763
BR - Brasile 1.597
UA - Ucraina 1.451
IT - Italia 1.109
HK - Hong Kong 1.105
TR - Turchia 913
GB - Regno Unito 905
VN - Vietnam 750
FI - Finlandia 705
RU - Federazione Russa 391
SE - Svezia 372
CA - Canada 225
PL - Polonia 202
MX - Messico 194
FR - Francia 172
IN - India 150
ID - Indonesia 145
AR - Argentina 117
JP - Giappone 114
NL - Olanda 94
ZA - Sudafrica 89
BD - Bangladesh 88
BE - Belgio 86
ES - Italia 64
EC - Ecuador 59
IQ - Iraq 57
LT - Lituania 52
IE - Irlanda 48
CZ - Repubblica Ceca 36
AT - Austria 32
CL - Cile 29
PK - Pakistan 28
PY - Paraguay 28
MA - Marocco 25
UZ - Uzbekistan 24
SA - Arabia Saudita 23
AE - Emirati Arabi Uniti 22
CO - Colombia 22
VE - Venezuela 22
IR - Iran 20
KE - Kenya 17
NP - Nepal 16
UY - Uruguay 16
KR - Corea 15
EG - Egitto 14
PE - Perù 13
TN - Tunisia 13
DZ - Algeria 12
AZ - Azerbaigian 11
IL - Israele 11
AU - Australia 10
CH - Svizzera 9
JO - Giordania 9
RO - Romania 9
DO - Repubblica Dominicana 8
NZ - Nuova Zelanda 8
BG - Bulgaria 7
SN - Senegal 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AL - Albania 6
GR - Grecia 6
LB - Libano 6
MY - Malesia 6
PA - Panama 6
TW - Taiwan 6
BH - Bahrain 5
BO - Bolivia 5
DK - Danimarca 5
EU - Europa 5
GY - Guiana 5
HN - Honduras 5
NG - Nigeria 5
NO - Norvegia 5
TT - Trinidad e Tobago 5
JM - Giamaica 4
LU - Lussemburgo 4
LV - Lettonia 4
NI - Nicaragua 4
RS - Serbia 4
SV - El Salvador 4
AM - Armenia 3
CY - Cipro 3
ET - Etiopia 3
HR - Croazia 3
KW - Kuwait 3
KZ - Kazakistan 3
MD - Moldavia 3
OM - Oman 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
CR - Costa Rica 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
Totale 50.645
Salva come PNG Salva come JPEG
Città #
Fairfield 3.307
Woodbridge 2.890
Singapore 2.856
Ashburn 2.835
Houston 1.989
Jacksonville 1.594
Ann Arbor 1.518
Chandler 1.392
Seattle 1.357
Wilmington 1.182
Cambridge 1.156
Santa Clara 1.119
Beijing 1.115
Dallas 1.103
Hong Kong 1.088
Munich 615
Izmir 546
Nanjing 457
Los Angeles 421
New York 375
Princeton 355
Ferrara 324
San Diego 281
Boardman 263
Helsinki 259
Ho Chi Minh City 253
Milan 223
Shanghai 205
São Paulo 181
Warsaw 180
Hanoi 144
Nanchang 138
London 129
Shenyang 129
Turku 128
Dearborn 127
Mexico City 118
Falkenstein 109
Tokyo 104
Hefei 102
Tianjin 97
Jakarta 96
Falls Church 92
Brooklyn 86
Brussels 82
Hebei 81
San Mateo 81
Norwalk 78
Moscow 77
Jiaxing 75
Bremen 74
Chicago 72
Frankfurt am Main 72
Orem 72
The Dalles 72
Montreal 70
Changsha 68
Buffalo 66
Denver 65
Redwood City 64
Atlanta 63
Mountain View 63
Johannesburg 61
Jinan 58
Rio de Janeiro 54
Toronto 53
San Francisco 52
Stockholm 51
Addison 48
Auburn Hills 48
Chennai 48
Dublin 47
Boston 46
Washington 46
Dong Ket 45
Guangzhou 44
Kunming 44
Zhengzhou 44
Bologna 43
Phoenix 43
Philadelphia 41
Poplar 41
Manchester 38
Belo Horizonte 35
Ankara 31
Mcallen 30
Columbus 29
Da Nang 29
Montréal 29
Mumbai 29
Amsterdam 28
Padova 28
Tappahannock 28
Des Moines 27
Ningbo 27
Orange 27
San Jose 27
Indiana 26
Brasília 25
Dhaka 25
Totale 35.808
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 957
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 347
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 338
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 316
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 292
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 278
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 260
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 254
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 245
A new selective antagonist of the nociceptin receptor 237
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 235
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 223
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 221
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 220
A new ligand for the urotensin II receptor 218
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 216
Actual concept of "probiotics": is it more functional to science or business? 213
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 212
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 206
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 206
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 206
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 206
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 205
null 205
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 205
The effect of guanethidine and local anaesthetics on the electrically stimulated mouse vas deferens 204
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 204
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 203
Structural Bacterial Molecules as Potential Candidates for an Evolution of the Classical Concept of Probiotics 203
AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices 203
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 202
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 201
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 201
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 200
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 197
Modulation of the NOP receptor signaling affects resilience to acute stress 197
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 197
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 195
Effects of vasoactive agents in healthy and diseased human saphenous veins 195
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 193
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 193
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 193
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 192
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease 192
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 192
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 191
Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone 191
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 190
Pharmacological characterization of tachykinin tetrabranched derivatives 190
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 189
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 189
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 188
[Nphe(1),Arg(14),Lys(15)]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray 188
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 188
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 188
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 187
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 187
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 186
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 185
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 185
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 185
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 184
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 182
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 181
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 180
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 180
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 179
Pharmacological characterization of nociceptin receptor: an in vitro study 179
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 178
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 178
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 178
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 177
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 177
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems 177
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 176
A simple method for electrical field stimulation of cultured granule cells 176
Pharmacological characterisation of novel kinin B2 receptor ligands 175
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 175
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 175
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 175
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands 174
B1 and B2 kinin receptors in various species 174
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 174
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505). 173
Sudden death from pulmonary thromboembolism: chronobiological aspects 172
Abdominal pain and diarrhoea caused by topical clindamycin phosphate 172
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 172
Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation 172
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 172
[Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats 171
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 171
Neuropeptide S receptor ligands: a patent review (2005-2016) 170
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 169
Structure-activity study at positions 3 and 4 of human neuropeptide S. 168
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 168
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 167
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 166
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 166
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 165
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 165
Totale 20.468
Salva come PNG Salva come JPEG
Categoria #
all - tutte 240.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.330
Totale 245.068
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.866 0 0 0 0 0 489 167 567 154 634 577 278
2021/20223.644 144 369 312 217 203 190 217 236 156 302 313 985
2022/20233.455 379 160 114 414 572 485 177 315 470 21 196 152
2023/20241.783 196 229 88 50 99 310 74 142 35 30 53 477
2024/20257.710 184 203 632 256 875 769 271 496 1.226 795 1.075 928
2025/202612.745 2.223 1.107 2.409 2.779 3.039 1.188 0 0 0 0 0 0
Totale 51.176